Dr. Singh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Barnes Jewish Hospital Plz
# Div
Saint Louis, MO 63110Phone+1 314-454-8304Fax+1 314-454-5902
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2016 - 2019- University of Pennsylvania Health SystemResidency, Internal Medicine, 2013 - 2016
Perelman School of Medicine at the University of PennsylvaniaClass of 2013
Certifications & Licensure
MO State Medical License 2019 - 2026
PA State Medical License 2013 - 2021
CA State Medical License 2015 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Analysis of pre-treatment tumors reveals gatekeepers of response to CAR T cells.Nathan Singh
Molecular Therapy. 2024-03-06 - 8 citationsSynthetic manipulation of the cancer-immunity cycle: CAR-T cell therapy.Nathan Singh, Marcela V Maus
Immunity. 2023-10-10 - 18 citationsEfficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G Karrison
Blood Advances. 2023-08-22
Journal Articles
- Genome-Editing Technologies in Adoptive T Cell Immunotherapy for CancerNathan Singh, Marco Ruella, Carl H June, Current Hematologic Malignancy Reports
Press Mentions
Precise Features of CAR T Cell-Resistant Cancer Have Been IdentifiedFebruary 3rd, 2020
Early Lineage T Cells Are Better for Immunotherapy in Pediatric Patients with ALL and LymphomaMarch 1st, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
